Ledger.Open graph →
SEC Form D · Amendment · filed June 23, 2014

G1 Therapeutics, Inc

Offering
$12.6M
Sold
$12.6M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Research Triangle Park, NC
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Mark Oei · Menlo Park, CADirectorCharles R. Nightingale · Irvine, CADirectorJeanmarie Guenot · San Francisco, CADirectorIrwin Gross · Menlo Park, CADirectorKristin S. Lowe · Santa Monica, CADirectorAntony D. Lundy · Greenwich, CTExec · DirectorJ. D. Divine · Santa Monica, CADirectorSteven J. Dietz · Santa Monica, CADirectorWilliam S. Lowe · Santa Monica, CAExec · DirectorCharles O. Svenson · New York, NYDirectorThomas K. Laundon · Chapel Hill, NCExecJay K. Strum · Research Triangle Park, NCExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗